# Current Master 1633 – Mapping Evidence Review v0.41

Stage `CURRENT_MASTER_RESEARCH_PARTIAL_1633_MANUAL_MAPPING_EVIDENCE_REVIEW` / `MAPPING_EVIDENCE_REVIEW_ONLY`.

The stage consumes exactly the v0.39 mapping audit and requires 239 unique WS_IDs: 151 `EXACT_PROVIDER_SYMBOL_NO_DATA`, 78 `CASE_NORMALIZATION_SUSPECT`, and 10 `SUFFIX_MAPPING_SUSPECT`. It is evidence-only. No universe, eligibility, master mapping, price, FX, Alpha Vantage, P0, Sector RS, or frozen-state mutation is permitted.

The implementation creates a complete 239-row evidence-review scaffold. It deliberately asserts no external evidence: all rows are `NOT_RESEARCHED`, confidence `UNRESOLVED`, and decision `UNRESOLVED_MANUAL` until primary-listing and provider URLs are manually documented. This prevents invented evidence and makes v0.42 application impossible without a later reviewed candidate set.

Required outputs are written below `output_current_master_research_partial_1633_mapping_evidence_review_v0_41/`. The next stage is result review before any v0.42 controlled mapping apply.
